Home NDC 67184-0569 Amikacin Sulfate
Product NDC 67184-0569
11-digit product format 671840569
Labeler code 67184
Product ID 67184-0569_0a56f2df-a71f-44a1-b7d0-98ee44e30e80
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Amikacin Sulfate
Dosage form INJECTION, SOLUTION
Route INTRAMUSCULAR; INTRAVENOUS
Labeler Qilu Pharmaceutical Co., Ltd.
Application ANDA218146
Marketing category ANDA
Marketing start 2024-03-19
Substance AMIKACIN SULFATE
Active strength 250 mg/mL
Pharmacologic classes Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A218146-001 AMIKACIN SULFATE AMIKACIN SULFATE EQ 250MG BASE/ML INJECTABLE / INJECTION AP 2024-03-19
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code A218146-001 AP
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A218146-001 AMIKACIN SULFATE EQ 250MG BASE/ML INJECTABLE / INJECTION AP 2024-03-19 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A218146-001 AMIKACIN SULFATE EQ 250MG BASE/ML INJECTABLE / INJECTION AP 2024-03-19 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A218146-001 AMIKACIN SULFATE EQ 250MG BASE/ML INJECTABLE / INJECTION AP 2024-03-19 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A218146-001 AMIKACIN SULFATE EQ 250MG BASE/ML INJECTABLE / INJECTION AP 2024-03-19 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A218146-001 AMIKACIN SULFATE EQ 250MG BASE/ML INJECTABLE / INJECTION AP 2024-03-19 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A218146-001 AMIKACIN SULFATE EQ 250MG BASE/ML INJECTABLE / INJECTION AP 2024-03-19 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A218146-001 AMIKACIN SULFATE EQ 250MG BASE/ML INJECTABLE / INJECTION AP 2024-03-19 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A218146-001 AMIKACIN SULFATE EQ 250MG BASE/ML INJECTABLE / INJECTION AP 2024-03-19 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A218146-001 AMIKACIN SULFATE EQ 250MG BASE/ML INJECTABLE / INJECTION AP 2024-03-19 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A218146-001 AMIKACIN SULFATE EQ 250MG BASE/ML INJECTABLE / INJECTION AP 2024-03-19 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A218146-001 AMIKACIN SULFATE EQ 250MG BASE/ML INJECTABLE / INJECTION AP 2024-03-19 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A218146-001 AMIKACIN SULFATE EQ 250MG BASE/ML INJECTABLE / INJECTION AP 2024-03-19 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A218146-001 AMIKACIN SULFATE EQ 250MG BASE/ML INJECTABLE / INJECTION AP 2024-03-19 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A218146-001 AMIKACIN SULFATE EQ 250MG BASE/ML INJECTABLE / INJECTION AP 2024-03-19 8072bd15b7f6…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A218146-001 AMIKACIN SULFATE EQ 250MG BASE/ML INJECTABLE / INJECTION AP 2024-03-19 a50c72e98297…
Observed Orange Book normalized TE history# Additional Listing Data#
Finished product Yes
Brand name base Amikacin Sulfate
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength AMIKACIN SULFATE 250 mg/mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination N6M33094FD Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 1723156 Internal RxNorm lookup 1723160 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 67184-0569-1 Amikacin Sulfate 2 mL in 1 VIAL, GLASS INJECTION, SOLUTION 2 3 67184-0569-2 Amikacin Sulfate 10 in 1 CARTON INJECTION, SOLUTION 10 3
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 67184-0569 AMIKACIN SULFATE INJECTION, SOLUTION [QILU PHARMACEUTICAL CO., LTD.] 1 Current NDC, 2 package rows 20240326_20fa61ef-11e2-4d01-82ea-b5412cefaead.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Sample Exclude flag Status 67184-0569-1 67184056901 2 mL in 1 VIAL, GLASS 2 ml Historical 67184-0569-2 67184056902 10 VIAL, GLASS in 1 CARTON (67184-0569-2) / 2 mL in 1 VIAL, GLASS (67184-0569-1) 2024-03-19 No No Current